(Q40845944)

24 September 2017

1 reference

title

Oral tolerization as a treatment of rheumatoid arthritis (English)

1 reference

24 September 2017

Trentham DE

1

1 reference

24 September 2017

1 August 1998

1 reference

Rheumatic Diseases Clinics of North America

24 September 2017

1 reference

24 September 2017

24

1 reference

24 September 2017

3

1 reference

24 September 2017

525-536

1 reference

A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Arthritogenicity of minor cartilage collagens (types IX and XI) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Collagen heterogeneity in human cartilage: Identification of several new collagen chains

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Cellular immunity to cartilage link protein in patients with inflammatory arthritis and non-arthritic controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Collagen type IX: evidence for covalent linkages to type II collagen in cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Proteoglycan-induced arthritis in balb/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

The role of digestive enzymes in orally induced immune tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Antigen-driven bystander suppression after oral administration of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

1 Alpha 2 alpha 3 alpha collagen is arthritogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

The regulation of immune responses to dietary protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Further biochemical and physicochemical characterization of minor disulfide-bonded (type IX) collagen, extracted from foetal calf cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Specificity of antibodies to type II collagen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Effects of oral administration of type II collagen on rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Autoimmunity to type II collagen an experimental model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970024-7

7 January 2021

10.1016/S0889-857X(05)70024-7

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9710885